| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/12/1995 | EP0662131A1 Nucleotide fragment of mycobacterial ribosomal rna 23s, probes and primers derived therefrom, reagent and method for detecting said fragment |
| 07/12/1995 | EP0662130A1 A method of producing hepatocyte growth factor and a cell line |
| 07/12/1995 | EP0662129A1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 07/12/1995 | EP0662128A1 Methods and compositions for controlling translation of hcv proteins |
| 07/12/1995 | EP0662125A1 Delivery of proteins by intermembrane transfer for preaccommodation of xenogeneic organ transplants and other purposes |
| 07/12/1995 | EP0662093A1 Hiv immunotherapeutics |
| 07/12/1995 | EP0662092A1 Activity-dependent neurotrophic factor |
| 07/12/1995 | EP0662091A1 Basophil granule proteins |
| 07/12/1995 | EP0662090A1 Peptide inhibitors of mitogenesis and motogenesis |
| 07/12/1995 | EP0662089A1 Compositions for and methods of treating cancer and autoimmune diseases |
| 07/12/1995 | EP0662088A1 Inhibitor of collagen-stimulated platelet aggregation |
| 07/12/1995 | EP0662087A1 Retinal pigmented epithelium derived neurotrophic factor |
| 07/12/1995 | EP0662086A1 Protein l and hybrid proteins thereof |
| 07/12/1995 | EP0662085A1 Peptide showing cross-reactivity with the anti-hepatitis b surface antigen antiserum |
| 07/12/1995 | EP0662084A1 Growth hormone potentiating molecules |
| 07/12/1995 | EP0662083A1 Synthetic peptide vaccine for chlamydia trachomatis |
| 07/12/1995 | EP0662082A1 Novel branched hybrid and cluster peptides effective in diagnosing and detecting non-a, non-b hepatitis |
| 07/12/1995 | EP0662079A1 Alpha-helix mimetics and methods relating thereto |
| 07/12/1995 | EP0662077A1 Cd27 ligand |
| 07/12/1995 | EP0662003A1 Oligonucleotide modulation of cell adhesion |
| 07/12/1995 | EP0661999A1 Anti-feline immunodeficiency virus (fiv) vaccines |
| 07/12/1995 | EP0661996A1 Mhc subunit conjugates useful in ameliorating deleterious immune responses |
| 07/12/1995 | EP0661990A1 Method for systemic treatment of catabolic conditions and systemic tissue injury |
| 07/12/1995 | EP0661988A1 Composition and treatment with biologically active peptides and chelating agents |
| 07/12/1995 | EP0661987A1 Morphogen-induced liver regeneration |
| 07/12/1995 | EP0661986A1 Brain-enhanced delivery of neuroactive peptides by sequential metabolism |
| 07/12/1995 | EP0661985A1 Cd8 binding domain peptides |
| 07/12/1995 | EP0661933A1 Morphogen-enriched dietary composition |
| 07/12/1995 | EP0661927A1 A process for producing beta-casein enriched products |
| 07/12/1995 | EP0654088A4 Novel flk-2 and analogs. |
| 07/12/1995 | EP0623142A4 Mammalian adipogenic factors. |
| 07/12/1995 | EP0612208A4 Pathogen-resistant transgenic plants. |
| 07/12/1995 | EP0573630A4 Immunoassay using synthetic htlv-ii peptides. |
| 07/12/1995 | EP0567586B1 Use of interleukin-10 in adoptive immunotherapy of cancer |
| 07/12/1995 | EP0390798B1 Method and compositions relating to regression-associated antigens |
| 07/12/1995 | EP0316319B1 Production and use of non-glycosylated IL-6 |
| 07/12/1995 | EP0215942B1 Polynucleotide assay reagent and method |
| 07/12/1995 | CN1105030A Erythropoietin analogs |
| 07/12/1995 | CN1105029A Process for producing solubilized protein |
| 07/11/1995 | US5432270 DNA encoding tracheal antimicrobial peptides |
| 07/11/1995 | US5432265 Process for the continuous removal of products from high pressure systems |
| 07/11/1995 | US5432264 Polypeptide with cysteine proteinase inhibitor activity, anticancer activity, and antiviral activity/effective against herper simplex/ |
| 07/11/1995 | US5432261 Motlin-like polypeptide and use thereof |
| 07/11/1995 | US5432260 Polypeptide derivatives of mannose to target glycoprotein receptors on macrophages; asthma; antiinflammatory agents; antitumor agents; immunoassay; imaging |
| 07/11/1995 | US5432202 Use of polyamines as ionic-channel regulating agents |
| 07/11/1995 | US5432159 N-(α-substituted-pyridinyl)carbonyl dipeptide antihypertensive agents |
| 07/11/1995 | US5432157 Chrysospermins, active peptides from apiocrea chrysosperma having a pharmacological effect and a use thereof |
| 07/11/1995 | US5432156 Therapeutic agent for digestive tract diseases |
| 07/11/1995 | US5432155 Conotoxins I |
| 07/11/1995 | US5432082 Expression and secretion vector in yeasts, useful for preparing heterologous proteins |
| 07/11/1995 | US5432081 Host cells transformed with the E. coli glucoronide permease gene |
| 07/11/1995 | US5432080 Treatment of inflammation in mammals |
| 07/11/1995 | US5432076 Alteration of the interaction of a T-cell receptor with a protein-tyrosine kinase |
| 07/11/1995 | US5432068 Control of male fertility using externally inducible promoter sequences |
| 07/11/1995 | US5432018 Peptide library and screening systems |
| 07/11/1995 | US5431899 Rotavirus VP6 as a diagnostic and targeting agent |
| 07/11/1995 | US5430935 Method for repairing a combustion chamber assembly |
| 07/11/1995 | CA1336307C Process for the preparation of a heat resistant non bitter water-soluble peptide, the product produced by the process, and nutrients, refreshments and dietetics comprising the product |
| 07/11/1995 | CA1336306C Hydrolyzable fluorescent substrates and analytical determinations using same |
| 07/11/1995 | CA1336272C Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles |
| 07/11/1995 | CA1336269C Expression of mammalian genes at high levels in host cells |
| 07/08/1995 | CA2139612A1 Novel inhibitor |
| 07/06/1995 | WO1995018382A1 A diagnostic antigen and a method of in vitro diagnosing an active infection caused by hepatitis c virus |
| 07/06/1995 | WO1995018380A1 Novel uses for gal4-receptor constructs |
| 07/06/1995 | WO1995018231A1 Vaccine compositions comprising live bacterial vectors for protection against yersinia pestis injection |
| 07/06/1995 | WO1995018230A1 Plant pathogen resistance genes and uses thereof |
| 07/06/1995 | WO1995018229A1 Antimicrobial proteins |
| 07/06/1995 | WO1995018228A1 Human circulating cytokine cc-1 |
| 07/06/1995 | WO1995018227A1 Phospholipid transfer proteins |
| 07/06/1995 | WO1995018226A1 Tuberous sclerosis 2 gene and uses thereof |
| 07/06/1995 | WO1995018225A1 Polycystic kidney disease 1 gene and uses thereof |
| 07/06/1995 | WO1995018224A1 Recombinant production of modified proteins lacking certain amino acids |
| 07/06/1995 | WO1995018221A1 Gene coding for adseverins |
| 07/06/1995 | WO1995018186A1 Modular design and synthesis of aminimide containing molecules |
| 07/06/1995 | WO1995018156A1 Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies |
| 07/06/1995 | WO1995018154A1 L-ap4 sensitive glutamate receptors |
| 07/06/1995 | WO1995018153A1 Glucagon analogs with serine replacements at position 16 having antagonistic activity |
| 07/06/1995 | WO1995018152A1 Derivatized calcitonins |
| 07/06/1995 | WO1995018151A1 Interferon glycoprotein |
| 07/06/1995 | WO1995018150A1 Novel human ciliary neurotrophic factor |
| 07/06/1995 | WO1995018149A1 Novel lectin and process for producing the same |
| 07/06/1995 | WO1995018148A1 T-cell epitopes |
| 07/06/1995 | WO1995018145A1 Conjugates of human mucin and a carbohydrate polymer and their use in cancer treatment |
| 07/06/1995 | WO1995018140A1 Olfactory genes and receptors |
| 07/06/1995 | WO1995017911A1 Homologous recombination for universal donor cells and chimeric mammalian hosts |
| 07/06/1995 | WO1995017907A1 Methods and compositions for inhibiting thrombogenesis |
| 07/06/1995 | WO1995017906A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 07/06/1995 | WO1995017905A1 Ileal bile acid transporter compositions and methods |
| 07/06/1995 | WO1995017904A2 Botulinum toxins for treating various disorders and associated pain |
| 07/06/1995 | WO1995017903A1 Modular design and synthesis of oxazolone-derived molecules |
| 07/06/1995 | WO1995017885A1 Inhibitors of urokinase plasminogen activator |
| 07/06/1995 | WO1995016919A3 Methods and compositions for the detection of colon cancers |
| 07/06/1995 | WO1995013103A3 Soluble factor stimulation of attachment and hemidesmosome assembly in epithelial cells |
| 07/06/1995 | WO1995012682A3 Viral vector with bovine viral diarrhea virus (bvdv) antigens |
| 07/06/1995 | WO1995011984A3 Recombinant adenoviral vector and methods of use |
| 07/06/1995 | DE4344397A1 New human circulating cytokine CC-1 and related nucleic acid |
| 07/06/1995 | DE19500030A1 New mpl ligand polypeptide, thrombopoietin |
| 07/06/1995 | CA2682117A1 The use of the neurotoxic component of a botulinum toxin for the treatment of a facial disease, disorder or condition |
| 07/06/1995 | CA2180359A1 Ileal bile acid transporter compositions and methods |
| 07/06/1995 | CA2180287A1 T-cell epitopes |